Neonatal characteristics in the untreated IGT group, control subjects, and the women with treated GDM/diabetes
| Control group (n = 810) | Untreated IGT (n = 211) | P* | GDM/DM (n = 116) | |
|---|---|---|---|---|
| Gestational age (weeks) | 39.2 ± 1.9 | 38.6 ± 1.8 | <0.001 | 38.3 ± 1.9 |
| Prematurity <37 weeks (%) | 5.4 | 11.4 | 0.005 | 13.9 |
| Birth weight (g) | 3,516 ± 571 | 3,799 ± 657 | <0.001 | 3,733 ± 681 |
| Macrosomic | ||||
| ≥4,000 g (%) | 16.4 | 33.0 | <0.001 | 30.4 |
| ≥4,500 g (%) | 3.3 | 12.4 | <0.001 | 10.4 |
| ≥5,000 g (%) | 0.2 | 4.3 | <0.001 | 4.3 |
| LGA (%) | 4.2 | 24.9 | <0.001 | 25.2 |
| SGA (%) | 2.2 | 0.5 | NS | 0.9 |
Data are rates or means ± SD.
↵* For control vs. IGT subjects by χ2 or Mann-Whitney U tests. SGA, small for gestational age.